Stocklytics Platform
Asset logo for symbol MIRM
Mirum Pharmaceuticals
MIRM60
$46.97arrow_drop_up2.57%$1.17
High Growth
Asset logo for symbol MIRM
MIRM60

$46.97

arrow_drop_up2.57%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Mirum Pharmaceuticals (MIRM) Stocklytics Forecast

Mirum Pharmaceuticals Inc (MIRM) is a biopharmaceutical company that focuses on the development and commercialization of therapies for rare liver diseases. One of the key aspects investors are interested in is the stock price prediction for MIRM. While it's important to note that stock predictions are not guaranteed, there are various factors that can be considered when formulating forecasts.
One method of predicting stock prices is through AI technology. AI algorithms analyze historical data, market trends, and other relevant factors to generate forecasts. Machine learning prediction for MIRM could provide valuable insights into the potential future performance of the stock. Though AI predictions are not infallible, they provide a data-driven approach to stock forecasting.
add Mirum Pharmaceuticals  to watchlist

Keep an eye on Mirum Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Mirum Pharmaceuticals (MIRM) stock?

Analysts have set a target price of $61.4 for Mirum Pharmaceuticals (MIRM), based on forecasts from 25 analysts. The predicted price range extends from a high of $83 to a low of $37. This represents a potential increase of up to 76.69% and a decrease of -21.23% from the current price of $46.98. These forecasts are as of 2023 Jan 10.
help

What are the analyst ratings for Mirum Pharmaceuticals (MIRM) stock?

The analyst ratings for Mirum Pharmaceuticals (MIRM) are distributed as follows: 11 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Mirum Pharmaceuticals .
help

What is the AI price prediction for Mirum Pharmaceuticals (MIRM) stock?

At present, there is no AI or machine-learning-based price prediction available for Mirum Pharmaceuticals (MIRM) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level